MYMD Pharmaceuticals Revenue, Growth & Competitor Profile

DBA AKERS BIOSCIENCES INC

Company Profile & Annual Report for MYMD Pharmaceuticals

Access the complete profile.

MYMD Pharmaceuticals Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	5411 Legal Services
Additional NAICS Codes	325413 In-Vitro Diagnostic Substance Manufacturing
Address	201 Grove Street West Deptford, NJ 08086

MYMD Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • MYMD Pharmaceuticals's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • MYMD Pharmaceuticals is classified as operating in the Legal Services industry, NAICS Code 5411.

MYMD Pharmaceuticals is a publicly traded company on using the ticker symbol AKER. Detailed information on company financials and operating reports can be found here: : AKER

MYMD Pharmaceuticals Annual Revenue and Growth Rate

MYMD Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$1 - $10 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: MYMD Pharmaceuticals's revenues are gauged from an analysis of company filings.

Investor Activity

MYMD Pharmaceuticals has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
May 31, 2024	4	100%	$27 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that MYMD Pharmaceuticals is developing and marketing. MYMD Pharmaceuticals doesn't have any recent trademark applications, indicating MYMD Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
AKERS BIO Distributorship services featuring in-vitro health screening and testing devices	05/13/2016
BREATHSCAN LYNC optical scanning device that reads and interprets breath test data	05/13/2016
AKERS WELLNESS Distributorship services featuring in vitro health screening and testing devices	05/13/2016

See all trademarks and details in the Full Report.

Market Share of MYMD Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as MYMD Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
AUSTIN 316 FIDUCIARY LIMITED	Oceanside, NY	100
CONSILIO	Washington, DC	66
LATHAM & WATKINS	Los Angeles, CA	54
KIRKLAND & ELLIS	Chicago, IL	49
CO STATE FRATERNAL ORDER OF POLICE	Westminster, CO	44
GREENBERG TRAURIG P.A.	Miami, FL	42
PROFESSIONAL LAW ENFORCEMENT A	Rochester, MI	38
CHG COMPANIES	Midvale, UT	35
BAKER & MCKENZIE	Chicago, IL	33

Nearby Competitors

These companies are similar in business line and location to MYMD Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ARCHER & GREINER A PROFESSIONAL	Voorhees, NJ	100
SECURITY RESOURCES INTERNATIONAL	Cherry Hill, NJ	50
CAPEHART & SCATCHARD P.A.	Mt. Laurel, NJ	35
FLASTER/GREENBERG P.C.	Cherry Hill, NJ	29
PARKER MCCAY P.A.	Mount Laurel, NJ	29
FELIX HOLDINGS	Marlton, NJ	27

Future Competition: MYMD Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as MYMD Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)